ESC Premium Access

New therapies in heart failure with reduced ejection fraction: For whom and when?

Event: ESC Asia with APSC & AFC 2020
Topic: Chronic Heart Failure
Session type: Debate Session
Date: 5 December 2020
Time: 15:40 - 16:10

Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

Sacubitril valsartan, ivabradine and omecamtic mecarbil.

Speaker: Professor M. Komajda (Paris, FR)
Thumbnail

Vericiguat and SGLT2 inhibitors.

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

New therapies in heart failure with reduced ejection fraction: For whom and when?

Thumbnail

2 speakers from this session

Professor Michel Komajda

Groupe Hospitalier Paris Saint-Joseph, Paris (France)
31 presentations
0 follower

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
95 presentations
11 followers

This platform is supported by

logo Novo Nordisk